IN THIS ARTICLE

Citations

1. Presti JC, et al. (2008). Benign prostatic hyperplasia (BPH) section of Neoplasms of the prostate gland. In EA Tanagho, JW McAninch, eds., Smith’s General Urology, 17th ed., pp. 348–370. New York: McGraw-Hill.

2. AUA Practice Guidelines Committee (2003). AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. Journal of Urology, 170(2, Part 1): 530–547. Available online: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=bph.

3. Roehrborn CG, et al. (2008). The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. Journal of Urology, 179(2): 616–621.

Other Works Consulted

• Aho TF, Gilling PJ (2003). Laser therapy for benign prostatic hyperplasia: A review of recent developments. Current Opinion in Urology, 13(1): 39–44.

• Helfand M, et al. (2007). Benign prostatic hyperplasia (BPH). Management in primary care—Screening and therapy. Department of Veterans Affairs Health Services Research and Development Service. Available online: http://www.hsrd.research.va.gov/publications/esp/BPH-2007.pdf.

• Murray MT, Pizzorno JE (2006). Serenoa repens (saw palmetto). In JE Pizzorno Jr, MT Murray, eds., Textbook of Natural Medicine, 3rd ed., vol.1, pp. 1245–1250. St. Louis: Churchill Livingstone Elsevier.

• Saw palmetto (2009). In A DerMarderosian et al., eds., Review of Natural Products. St. Louis: Wolters Kluwer Health.

• Soliman SA, et al. (2007). Rotoresection versus transurethral resection of the prostate: Short-term evaluation of a prospective randomized study. Journal of Urology, 177(3): 1036–1039.

• Wilt TJ, N'Dow J (2008). Benign prostatic hyperplasia. Part 1—Diagnosis. BMJ, 336(7636): 146–149.